Skip to main content
NIH funding notice PA-19-077

Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)

Closed on December 2, 2021.

Posted
November 26, 2018
Close date
December 2, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,928,900 in first-year total cost, median $589,845.

Most frequent study sections

  1. Vaccines Against Microbial Diseases Study Section[VMD]7
  2. Immunity and Host Defense Study Section[IHD]1

Most frequent institutions

  1. MASSACHUSETTS GENERAL HOSPITAL2
  2. CAUCASECO SCIENTIFIC RESEARCH CENTER1
  3. JAMES COOK UNIVERSITY OF NO QUEENSLAND1
  4. JOHNS HOPKINS UNIVERSITY1
  5. OREGON HEALTH & SCIENCE UNIVERSITY1
Competing awards under PA-19-077 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022A universal malaria T cell vaccine based on HLA-E presentation1R01AI168092-01JUNQUEIRA, CAROLINEWILDER, BRANDON KEITHOREGON HEALTH & SCIENCE UNIVERSITY, OR$752,069IHD
2022Accelerating Malaria Vaccines with a Custom Preclinical Humanized Mouse Model Platform1R01AI168114-01BATISTA, FACUNDO DAMIANMASSACHUSETTS GENERAL HOSPITAL, MA$704,453VMD
2022Developing a multi-component vaccine harnessing potent antibody and cellular responses against the blood-stage of Plasmodium falciparum1R01AI155598-01A1SRINIVASAN, PRAKASHSTANISIC, DANIELLEJOHNS HOPKINS UNIVERSITY, MD$683,786VMD
2022Human-informed data-driven development of next-generation T cell vaccine against malaria1R01AI162830-01A1DOOLAN, DENISE L.JAMES COOK UNIVERSITY OF NO QUEENSLAND$495,904VMD
2021Defining functional humoral correlates of immunity to guide vaccine design1R01AI151178-01A1ALTER, GALITMASSACHUSETTS GENERAL HOSPITAL, MA$850,980VMD
2020Rationally-Designed, Spontaneous-Particleized Pfs48/45 for a Multivalent Malaria Vaccine1R01AI148557-01A1JULIEN, JEAN-PHILIPPELOVELL, JONATHAN FSTATE UNIVERSITY OF NEW YORK AT BUFFALO, NY$492,238VMD
2020Exploiting cross-reactive, conserved epitopes in Plasmodium vivax to develop a vaccine against falciparum placental malaria.1R01AI150944-01YANOW, STEPHANIEUNIVERSITY OF ALBERTA, AB$490,848VMD
2020Discovery and preclinical evaluation of Plasmodium falciparum and P. vivax coiled coil antigens for malaria vaccine development1R01AI148843-01HERRERA VALENCIA, SOCRATESCAUCASECO SCIENTIFIC RESEARCH CENTER$458,622VMD

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.